Shared Investigator Platform vs D798EC00001
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
Shared Investigator Platform
This mobile application allows clinical trial site users to manage their actions on the Shared Investigator Platform. It facilitates easy login, E-signing, reviewing pending actions, accepting study invitations, and managing study staff. Users can also access study documents, complete tasks, and receive important notifications.
- User-friendly interface
- E-sign functionality
- Biometric authentication
- Review pending actions
- Accept study invitations
- Manage study staff
- Access study documents
Read full descriptionHide full description
The Shared Investigator Platform (Cognizant SIP) Mobile App features a user friendly interface to navigate and manage your actions on the Shared Investigator Platform. With this app, site users can easily login and E-sign using their existing SIP credentials and enable biometric authentication to simplify the subsequent login and E-signature processes. This app offers an easy review of the pending actions, accept study invitations, View and generate FDA Form1572, view the study news, acknowledge safety notifications, add and manage study site staff, view study documents, complete Document Exchange tasks published by your sponsor organizations and receive push notifications of latest study news published and assigned tasks.
D798EC00001
Read full descriptionHide full description
MedImmune D798EC00001 eCOA App is intended for use to collect patient reported outcomes relating to a clinical trial. Patients must be given accounts by a participating site in order to log in to the app. Patients can report daily symptom changes, and report changes to health associated with the study
Screenshots
Verdict
The clearest difference is update cadence: D798EC00001 at every 6 weeks against Shared Investigator Platform's every 6 months. Shared Investigator Platform's advantage is iOS requirement (15.6 vs 17.0). On price, ads, in-app purchases and device support there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
Shared Investigator Platform ships an update every 6 months, D798EC00001 every 6 weeks. The most recent releases landed on November 3, 2026 and November 12, 2026 respectively.
| Parameter | Shared Investigator Platform | D798EC00001 |
|---|---|---|
| Price | Free | Free |
| Rating | 5.0 (5 ratings) — better | — |
| Positive reviews | 100.0% of reviews | — |
| Number of ratings | 5 — better | — |
| Update frequency | Every 6 months | Every 6 weeks — better |
| Ads | No | No |
| In-app purchases | No | No |
| Monetization | Free | — |
| Devices | iPhone, iPad, iPod — better | iPhone, iPad |
| Requires iOS | 15.6 — better | 17.0 |
| Further details — not scored | ||
| Size | 49 MB | 88 MB |
| Age rating | 17+ | 12+ |
| Developer | Cognizant Technology Solutions | ERT,INC |
In-app purchases
Shared Investigator Platform
No in-app purchases
D798EC00001
No in-app purchases
Questions
Is Shared Investigator Platform free?
Is D798EC00001 free?
Do Shared Investigator Platform or D798EC00001 have ads?
Which is updated more often, Shared Investigator Platform or D798EC00001?
Other comparisons















